Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1141-1150 of 1760 for cancer

Edit search filters
  1. A Study of IPI-926 for Patients with Myelofibrosis

    Scottsdale/Phoenix, AZ

  2. A Study To Evaluate ADP-A2M4 With Pembrolizumab To Treat Recurrent Or Metastatic Head And Neck Cancer

    Scottsdale/Phoenix, AZ

  3. Pazopanib Hydrochloride in Treating Patients with Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

    Jacksonville, FL, Rochester, MN

  4. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia

    Rochester, MN

  5. Minimally Invasive Molecular Approaches For The Diagnosis Of Barrett's Esophagus And Esophageal Adenocarcinoma

    Scottsdale/Phoenix, AZ, Austin, MN, Eau Claire, WI, Jacksonville, FL, Mankato, MN, Rochester, MN

  6. Evaluation Of T-RFA And RF-TVA Prior To/Following Radiation Therapy To Treat Painful Metastatic Vertebral Body Tumor(s)

    Rochester, MN

  7. First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects with Acute Myelogenous Leukemia and Selected B-cell Cancers

    Jacksonville, FL

  8. GRAVITAS-301: A Study Of Itacitinib Or Placebo In Combination With Corticosteroids For Treatment Of Acute Graft-Versus-Host Disease

    Rochester, MN

  9. Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients with Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. A Study of Aplidin for Treating Patients with Primary Myelofibrosis, Post Polycythemia Vera or Essential Thrombocythemia Myelofibrosis

    Rochester, MN

.

Mayo Clinic Footer